Jeffrey D Capello - Net Worth and Insider Trading
Jeffrey D Capello Net Worth
The estimated net worth of Jeffrey D Capello is at least $10 Million dollars as of 2023-03-31. Jeffrey D Capello is the SVP & CFO of PerkinElmer Inc and owns about 73,139 shares of PerkinElmer Inc (PKI) stock worth over $10 Million. Jeffrey D Capello is also the EVP & CFO of Boston Scientific Corp and owns about 447 shares of Boston Scientific Corp (BSX) stock worth over $22,171. Details can be seen in Jeffrey D Capello's Latest Holdings Summary section.
Transaction Summary of Jeffrey D Capello
Jeffrey D Capello Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey D Capello owns 7 companies in total, including Biogen Inc (BIIB) , Millendo Therapeutics Inc (MLND) , and Salarius Pharmaceuticals Inc (SLRX) among others .
Click here to see the complete history of Jeffrey D Capello’s form 4 insider trades.
Insider Ownership Summary of Jeffrey D Capello
|Ticker||Comapny||Transaction Date||Type of Owner|
|BIIB||Biogen Inc||2017-12-11||EVP & Chief Financial Officer|
|MLND||Millendo Therapeutics Inc||2018-07-04||director|
|SLRX||Salarius Pharmaceuticals Inc||2015-04-01||director|
|BSX||Boston Scientific Corp||2013-08-29||EVP & Chief Financial Officer|
|PKI||PerkinElmer Inc||2005-01-25||Chief Accounting Officer|
|TPST||Tempest Therapeutics Inc||2013-06-07||director|
Jeffrey D Capello Latest Holdings Summary
Jeffrey D Capello currently owns a total of 2 stocks. Among these stocks, Jeffrey D Capello owns 73,139 shares of PerkinElmer Inc (PKI) as of May 31, 2007, with a value of $10 Million and a weighting of 99.77%. Jeffrey D Capello also owns 447 shares of Boston Scientific Corp (BSX) as of November 27, 2013, with a value of $22,171 and a weighting of 0.23%.
Latest Holdings of Jeffrey D Capello
|Ticker||Comapny||Latest Transaction Date||Shares Owned||Current Price ($)||Current Value ($)|
|BSX||Boston Scientific Corp||2013-11-27||447||49.60||22,171|
Holding Weightings of Jeffrey D Capello
Jeffrey D Capello Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey D Capello has made a total of 0 transactions in PerkinElmer Inc (PKI) over the past 5 years. The most-recent trade in PerkinElmer Inc is the sale of 37,500 shares on May 31, 2007, which brought Jeffrey D Capello around $990,000.
According to the SEC Form 4 filings, Jeffrey D Capello has made a total of 0 transactions in Boston Scientific Corp (BSX) over the past 5 years. The most-recent trade in Boston Scientific Corp is the sale of 108,595 shares on November 27, 2013, which brought Jeffrey D Capello around $1 Million.
Insider Trading History of Jeffrey D Capello
Jeffrey D Capello Trading Performance
Jeffrey D Capello Ownership Network
Ownership Network List of Jeffrey D Capello
Ownership Network Relation of Jeffrey D Capello
Jeffrey D Capello Owned Company Details
What does Biogen Inc do?
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.
Who are the key executives at Biogen Inc?
Jeffrey D Capello is the EVP & Chief Financial Officer of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , director & President and CEO Christopher Viehbacher , and Head of Pharm Ops and Tech Nicole Murphy .
Biogen Inc (BIIB) Insider Trades Summary
Over the past 18 months, Jeffrey D Capello made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 5,610 shares made by Ginger Gregory , and a net sale of 5,532 shares made by Susan H Alexander .
In summary, during the past 3 months, insiders sold 0 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,142 shares of Biogen Inc (BIIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,142 shares.
Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biogen Inc Insider Transactions
Jeffrey D Capello Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey D Capello. You might contact Jeffrey D Capello via mailing address: C/o Neogen Corp., 620 Lesher Place, Lansing Mi 48912.